CCL5 and metabolic dysfunction-associated steatotic liver disease: The CCL2-CCR2 and CCL5-CCR5 chemokine signalling axes stimulates monocyte recruitment to insulted adipose tissue sites and has been suggested as therapeutic target to resolve inflammation in NAFLD (Kazankov et al., 2019).